Regorafenib overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter in colorectal cancer: In vitro and in vivo study-Reference-Cited by-同舟云学术

Regorafenib overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter in colorectal cancer: In vitro and in vivo study

Published:2017-06 Issue: Volume:396 Page:145-154
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Wang Yi-Jun,Zhang Yun-Kai,Zhang Guan-Nan,Al Rihani Sweilem B.,Wei Meng-Ning,Gupta Pranav,Zhang Xiao-Yu,Shukla Suneet,Ambudkar Suresh V.,Kaddoumi Amal,Shi Zhi,Chen Zhe-Sheng

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference56 articles.

1. Development of inhibitors of ATP-binding cassette drug transporters–present status and challenges;Shukla;Expert Opin. Drug Metab. Toxicol.,2008

2. The emergence of drug transporter-mediated multidrug resistance to cancer chemotherapy;Wu;Mol. Pharm.,2011

3. The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade;Kathawala;Drug Resist. Updat.,2015

4. ABC transporters, mechanisms and biology: an overview;Holland;Essays Biochem.,2011

5. Molecular basis of antifolate resistance;Assaraf;Cancer Metastasis Rev.,2007

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of dual JAK/HDAC inhibitor with regorafenib synergistically reduces tumor growth, metastasis, and regorafenib-induced toxicity in colorectal cancer;Journal of Experimental & Clinical Cancer Research;2024-07-11

2. Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future success;Advances in Cancer Biology - Metastasis;2024-07

3. Drug Resistance in Hepatocellular Carcinoma: Theoretical Basis and Therapeutic Aspects;Frontiers in Bioscience-Landmark;2024-02-04

4. Deciphering treatment resistance in metastatic colorectal cancer: roles of drug transports, EGFR mutations, and HGF/c-MET signaling;Frontiers in Pharmacology;2024-01-10

5. RPF2 mediates the CARM1‑MYCN axis to promote chemotherapy resistance in colorectal cancer cells;Oncology Reports;2023-11-21